<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">Tuberculous infections</z:e> in patients with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> and hematopoietic stem cell transplant vary in incidence, complications and response to treatment </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND MATERIALS: A retrospective study of patients with various benign and malignant <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> and recipients of hematopoietic stem cell transplant who were treated at Riyadh Armed Forces Hospital, Saudi Arabia between January 1991 and December 2002 and who developed <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculous infections</z:e> was conducted </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">Tuberculous infections</z:e> occurred in eighteen patients with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> and hematopoietic stem cell transplant </plain></SENT>
<SENT sid="3" pm="."><plain>The main associated factors were: reduced immunity due to the primary hematological disorder, age more than 50 years and the administration of cytotoxic chemotherapy, steroids or radiotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>These <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> frequently involved the lungs and predominantly occurred in males and in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In patients treated with intravenous cytotoxic chemotherapy, <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculous infections</z:e> tended to occur earlier and also tended to be more disseminated compared to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> occurring in patients treated with oral chemotherapy </plain></SENT>
<SENT sid="6" pm="."><plain>Anti-<z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculous</z:e> treatment was given to 16 patients and it was successful in 15 of these patients </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">Tuberculous infections</z:e> cause significant morbidity and mortality in patients with various <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> and in recipients of hematopoietic stem cell transplant </plain></SENT>
<SENT sid="8" pm="."><plain>The early administration of anti-<z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculous</z:e> therapy and compliance with drug treatment are associated with successful outcomes while delayed management, drug resistance and the presence of miliary <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> are associated with poor prognosis and high mortality rates </plain></SENT>
</text></document>